Proteasome as an Emerging Therapeutic Target in Cancer

Publisher： Bentham Science Publishers

E-ISSN： 1873-4286|13|5|471-485

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.5, 2007-02, pp. : 471-485

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Ubiquitin- and proteasome-dependent pathway of protein degradation as an emerging therapeutic target

By Wójcik C.  

Expert Opinion on Therapeutic Targets, Vol. 4, Iss. 1, 2000-02 ,pp. : 89-111

Informa Healthcare

Access to resources Recommend Favorite

The Immunoproteasome: An Emerging Therapeutic Target

By  

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 23, 2011-12 ,pp. : 2923-2930

Bentham Science Publishers

Access to resources Recommend Favorite

CD74: an emerging opportunity as a therapeutic target in cancer and autoimmune disease

By Borghese Federica   Clanchy Felix IL  

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 3, 2011-03 ,pp. : 237-251

Informa Healthcare

Access to resources Recommend Favorite

The proteasome: a new `irrational' target for cancer treatment

By  

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 2-2

Adis International

Access to resources Recommend Favorite

Akt as a therapeutic target in cancer

By Steelman Linda S   Stadelman Kristin M   Chappell William H   Horn Stefan   Bäsecke Jörg   Cervello Melchiorre   Nicoletti Ferdinando   Libra Massimo   Stivala Franca   Martelli Alberto M   McCubrey James A  

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 9, 2008-09 ,pp. : 1139-1165

Informa Healthcare

Access to resources Recommend Favorite